Teoxane Laboratories
Nicolas Caill is a skilled professional with expertise in toxicology and post-market surveillance. Currently serving as Post-Market Surveillance Lead at Teoxane Laboratories since March 2018, Nicolas has previously held positions such as Medical Device Vigilance Specialist at ANSM and Toxicologist at RNI Conseil. With an academic background that includes a Master's degree in Toxicology from Université de Bretagne Occidentale and a Master 2 in Human Toxicology, Risk Assessment and Vigilance from Université Paris Cité, Nicolas has contributed to critical research and risk assessment projects, including work on extracorporeal liver purification systems and client inquiries related to cosmetic and dietary supplement ingredients.
This person is not in any teams
Teoxane Laboratories
1 followers
When Madame Valérie Taupin created TEOXANE Laboratories in Geneva in 2003, her vision was crystal clear: to satisfy the ever demanding aesthetic market with high performance, avant-garde products based on rigorous scientific research. Today our focus remains unchanged. We are dedicated to designing and manufacturing hyaluronic acid dermal fillers and skincare products, applying industry-leading expertise and high-quality standards. Building on a firm commitment to innovation and patient satisfaction, we have strengthened our presence. In 2023, TEOXANE has over 10 subsidiaries and is present in more than 95 countries worldwide. TEOXANE is now confirmed as a major player in aesthetic medicine and skincare, offering effective solutions to practitioners worldwide, helping women and men who want to look and feel their best at all times and help them maintain their beauty in the future. Our core values of Innovation, Culture of Excellence and Independence continue to set us apart and guide our ambitions.